Kristian Stengaard-Pedersen

A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearch

  • Mette Bjørndal Axelsen, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark.
  • ,
  • Iris Eshed, Sheba Medical Center - Radiology, Tel HaShomer, Israel, Israel
  • Kim Hørslev-Petersen, Kong Christian X's Gigthospital, Denmark
  • Kristian Stengaard-Pedersen
  • Merete Lund Hetland, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark., Denmark
  • Jakob Møller, Denmark
  • Michael Peter Junker, Lost+Found (ADM), Denmark
  • Jan Pødenphant
  • ,
  • Annette Schlemmer
  • Torkell Ellingsen, Denmark
  • Palle Ahlquist
  • ,
  • Hanne Lindegaard, Center for Design, Innovation og Bæredygtig Omstilling, Denmark
  • Asta Linauskas
  • Mette Yde Dam
  • ,
  • Ib Hansen
  • Hans Christian Horn, Reumatologi, Denmark
  • Christian Gytz Ammitzbøll, Denmark
  • Anette Jørgensen, Denmark
  • Sophine Boysen Krintel, Institut for Klinisk Medicin, Denmark
  • Johnny Raun, Reumatologisk Afdeling, Fredericia Sygehus
  • ,
  • Niels Steen Krogh, ZiteLab ApS, Refshalevej 110a, dk - 1432 københavn k, Denmark
  • Julia Sidenius Johansen, Medicinsk og Onkologisk afd., Herlev Hospital; Herlev Ringvej 75, 2730 Herlev, Denmark
  • Mikkel Østergaard, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital at Glostrup, Glostrup, Denmark., Denmark
  • OPERA study group
To investigate whether a treat-to-target strategy with methotrexate and intra-articular glucocorticosteroid injections suppresses MRI inflammation and halts structural damage progression in patients with early rheumatoid arthritis (ERA), and whether adalimumab provides an additional effect.
Original languageEnglish
JournalAnnals of the Rheumatic Diseases
ISSN0003-4967
DOIs
Publication statusPublished - 16 Jan 2014

See relations at Aarhus University Citationformats

ID: 70844236